Busca avançada
Ano de início
Entree
(Referência obtida automaticamente do Web of Science, por meio da informação sobre o financiamento pela FAPESP e o número do processo correspondente, incluída na publicação pelos autores.)

Quantification of mycophenolic acid in human plasma by liquid chromatography with time-of-flight mass spectrometry for therapeutic drug monitoring

Texto completo
Autor(es):
Antunes, Natalicia J. [1, 2, 3] ; Ince, Nina [3, 4] ; Raymond, Jason [3, 4] ; Kipper, Karin [3, 5] ; Couchman, Lewis [3, 6] ; Holt, David W. [3] ; De Nucci, Gilberto [1] ; Johnston, Atholl [2, 3]
Número total de Autores: 8
Afiliação do(s) autor(es):
[1] Univ Estadual Campinas, Dept Pharmacol, Fac Med Sci, Campinas, SP - Brazil
[2] Queen Mary Univ London, William Harvey Res Inst, Barts & London Sch Med & Dent, Clin Pharmacol, London - England
[3] St Georges Univ London, Analyt Serv Int Ltd, London - England
[4] Univ Surrey, Dept Chem, Guildford, Surrey - England
[5] Univ Tartu, Inst Chem, Tartu - Estonia
[6] Kings Coll London, Pharmaceut Sci Clin Acad Grp, London - England
Número total de Afiliações: 6
Tipo de documento: Artigo Científico
Fonte: BIOMEDICAL CHROMATOGRAPHY; v. 35, n. 3 NOV 2020.
Citações Web of Science: 0
Resumo

This study presents, for the first time, the development and validation of a liquid chromatography and time-of-flight mass-spectrometry (LC-TOF-MS) based assay to quantify mycophenolic acid (MPA) in patient samples as part of a routine therapeutic drug monitoring service. MPA was extracted from 50 mu l human plasma by protein precipitation, using sulindac as internal standard (IS). Separation was obtained on a Luna (TM) Omega polar C-18 column kept at 40 degrees C. The mobile phase consisted of a mixture of acetonitrile-deionized water (50:50, v/v) with 0.1% formic acid at a flow rate of 350 mu l/min. Analyte and IS were monitored on a TOF-MS using a Jet-Stream (TM) (electrospray) interface running in positive mode. Assay performance was evaluated by analysing patient plasma (N = 69) and external quality assessment (N = 6) samples. The retention times were 2.66 and 2.18 min for MPA and IS, respectively. The lower limit of quantification of MPA was 0.1 mu g/ml. The within- and between-assay reproducibility results ranged from 1.81 to 10.72%. Patient and external quality assessment sample results were comparable with those obtained previously by an in-house validated LC-MS/MS method. This method showed satisfactory analytical performance for the determination of MPA in plasma over the calibration range of 0.1-15.0 mu g/ml. (AU)

Processo FAPESP: 16/22506-1 - Metabolismo do dapaconazol
Beneficiário:Natalícia de Jesus Antunes
Modalidade de apoio: Bolsas no Brasil - Pós-Doutorado